Hydantoin intermediates for the synthesis of omapatrilat and methods for producing and using the same
US6300503A · kind A · utility
3Cited by
8References
38Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 7, 2000 |
| Grant date | Oct 9, 2001 |
| Priority date | — |
| Expiry date | Jun 7, 2020 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D317/30
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Omapatrilat (I) is a potent inhibitor of angiotensin-converting enzyme (ACE) and neutral endopeptidase (NEP) both in vitro and in vivo and is currently undergoing large scale clinical trials as an anti-hypertensive. Omapatrilat may be synthesized using the S-stereoisomer of compound (V). Compound (V) may be prepared from a novel hydantoin (III). The hydantoin may be prepared from a monoacetal (XI) or via a dinitrile (V).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.